EMEA PHARMACEUTICAL NEWS IN BRIEFS
September 1st, 2009
BY KEITH NUTHALL
THE EUROPEAN Medicines Agency (EMEA) has released a revised priority list for studies into off-patent paediatric medicinal products, for which researchers can receive funding through the European Commission's seventh framework programme -
http://www.emea.europa.eu/pdfs/human/paediatrics/41493609en.pdf;
Other EMEA news:
*It has published guidelines for non-clinical and clinical uses of biological medicinal products containing erythropoietins, which are responsible for stimulating red blood cell production - ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.